(A) Example showing the instantaneous firing rate of a BACHD STN neuron in control conditions, during the application of catalase (250 U/ml), and during co-application of catalase and glibenclamide (100 nM). (B1) Example of BACHD STN neuron firing in control conditions (marked 1 in A). (B2) Example of elevated firing during break down of H2O2 by catalase (marked 2 in A). (B3) Example showing no further elevation of firing rate during additional inhibition of KATP channels with glibenclamide (marked 3 in A). (C) Population data from 4–6-month old BACHD mice showing an increase in the frequency and regularity of firing following break down of H2O2, with no further changes upon KATP channel inhibition. (D) Population data showing an increase in the frequency and regularity of firing following KATP channel inhibition with no further change in firing rate and a slight increase in firing regularity upon H2O2 break down. *p < 0.05. ns, not significant. Data for panels C–D provided in Figure 8—source data 1.
DOI:
http://dx.doi.org/10.7554/eLife.21616.021
Figure 8—source data 1. Autonomous firing frequency and CV for WT and BACHD STN neurons under control conditions and following catalase and/or glibenclamide application in Figure 8C–D.